Tranexamic acid for brain bleeding
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether the drug tranexamic acid can help stop bleeding in the brain when given early. It is for people with a spontaneous brain bleed who are awake and can be treated within 6 hours.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a spontaneous brain bleed (not caused by injury) that is in the upper part of the brain.
- You are at least 18 years old.
- The bleed started less than 6 hours ago.
- You are awake enough to follow commands (GCS score 8 or higher).
- The bleed is large enough depending on its location—for example, more than 7 ml if in the thalamus or internal capsule, or more than 30 ml if in the putamen or outer brain layer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an antibiotic called minocycline can help people who have had a bleeding stroke (intracerebral hemorrhage). The drug may reduce brain swelling and improve recovery. You must start treatment within 24 hours of the bleeding.
This trial tests a non-invasive ultrasound device to help clear blood clots from the brain after a spontaneous bleed. It may be an option for people with small to medium-sized bleeds who do not need surgery.
This study tests a combination of a minimally invasive surgery to remove the brain bleed and a medication called deferoxamine (which may help reduce damage from the bleed). The goal is to see if this combination helps improve recovery after a brain hemorrhage.
This study tests whether a drug called tranexamic acid (TXA) can help control bleeding in trauma patients. It uses a special blood test (thromboelastography) to monitor how well your blood clots during treatment.
This trial studies whether tranexamic acid (a medicine that helps blood clot) can improve outcomes after a spontaneous (not caused by injury) brain bleed. It is designed for adults who arrive soon after stroke symptoms start and meet several safety and timing requirements.
This trial tests whether giving a drug called tranexamic acid (helps stop bleeding) along with very careful blood pressure lowering can reduce bleeding growth and improve recovery after a brain bleed. It is for people who arrive at the hospital very quickly (within 2 hours) after symptoms start.
Hear when a new Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.